GLP-1 / Weight
CagriSema
A fixed combination of the amylin analogue cagrilintide with semaglutide, studied for weight loss beyond semaglutide alone — not yet registered in the UAE.
Also known as: Cagrilintide + Semaglutide
- ✓ Reported ~22.7% weight loss at 68 weeks in Phase 3
- ✓ Dual amylin + GLP-1 satiety mechanism
- ✓ Exceeded semaglutide monotherapy in trials
CagriSema
GLP-1 / Weight
from
Not commercially available
UAE access
Licensed physician protocols onlyEmerging / not yet registered in the UAE. CagriSema (Novo Nordisk) is investigational and not approved or available for prescription in the UAE. This page is educational only.
Find a DHA-licensed clinic offering CagriSema →Pricing
Book this protocol in the UAE
Links open the clinic’s relevant service page. Always confirm availability and pricing directly before booking.
How it works
CagriSema pairs semaglutide (a GLP-1 receptor agonist) with cagrilintide (a long-acting amylin analogue). Amylin and GLP-1 act on complementary satiety pathways, so the combination targets appetite and food intake through two mechanisms. In Phase 3 (REDEFINE) research the combination produced greater weight loss than semaglutide monotherapy — around 22.7% at 68 weeks in reported data.
Not sure if this fits your goals?
2-min match →Key benefits
Protocol overview
CagriSema is investigational in most markets and has no approved general protocol. Trial use is a once-weekly subcutaneous injection with titration. It is not available for prescription in the UAE; information here is educational only and any future use must be physician-supervised within an approved pathway.
Not sure if this fits your goals?
2-min match →Side effects
- Gastrointestinal effects during titration
- Reduced appetite and early satiety
- Possible dehydration if intake drops sharply
- Long-term safety still being established
Not suitable if
- Personal or family history of medullary thyroid carcinoma or MEN2
- History of pancreatitis
- Pregnancy or breastfeeding
Licensed partners
Licensed online & at-home care
Every partner below is DHA/MOHAP-licensed. Telehealth platforms have a licensed physician review and prescribe before anything is dispensed; online pharmacies dispense against a valid prescription with home delivery.
At-home & telehealth programmes
ZenDXB
Clinic + shopMOH-licensed Dubai clinic & online shop (JLT) — doctor-reviewed peptide packages, delivered, with WhatsApp ordering.
DarDoc
Doctor-reviewedDHA-licensed at-home care across all seven Emirates — doctor-reviewed GLP-1 and peptide programmes, with licensed nurses at your door.
Valeo Health
Doctor-supervisedDoctor-supervised at-home GLP-1 programme with lab tests and personalised coaching, delivered by DHA-licensed practitioners.
Metabolic.Health
Physician-ledPhysician-led metabolic and weight-loss programmes with GLP-1 therapy and continuous monitoring.
TruCare Plus
Doctor-reviewedDHA-licensed at-home peptide therapy with prefilled pens — doctor review and home bloodwork first, then nurse administration or trained self-use.
A valid prescription from a DHA- or DOH-licensed physician is required in every case. We do not sell or dispense any medication; links are referrals to licensed providers only.
Clinics offering this
Every provider below is licensed — a DHA/DOH physician assesses you first, and all therapy is supervised.
No directory clinics list this compound yet — the licensed at-home platforms above cover it.